A Immuno-bridging and Immunization Schedules Study of COVID-19 Vaccine (Vero Cell), Inactivated
Clinical trial NCT04863638 · UNKNOWN
Trial details
- NCT number
- NCT04863638
- Sponsor
- China National Biotec Group Company Limited
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-29
- Primary completion
- 2021-12-20
- Enrollment
- 4400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.